greeksoup/ stock research
Stock research / United States / AME · Industrial Instruments For Measurement, Display, And Control · NYSE

AMETEK Inc. (AME)

AMETEK manufactures electronic instruments and electromechanical devices, with operations in North America, Europe, Asia and South America and principal offices in Berwyn, Pennsylvania. It is incorporated in Delaware, and its predecessor was originally incorporated there in 1930 as American Machine and Metals. The products are sold worldwide through two operating groups, which are also the reportable segments: Electronic Instruments, referred to as EIG, and Electromechanical, referred to as EMG.

AMETEK Inc.

AMETEK manufactures electronic instruments and electromechanical devices, with operations in North America, Europe, Asia and South America and principal offices in Berwyn, Pennsylvania. It is incorporated in Delaware, and its predecessor was originally incorporated there in 1930 as American Machine and Metals. The products are sold worldwide through two operating groups, which are also the reportable segments: Electronic Instruments, referred to as EIG, and Electromechanical, referred to as EMG.

Electronic Instruments

EIG designs and manufactures analytical, test and measurement instruments for the process, aerospace, medical, research, power and industrial markets. It employed approximately 12,800 people at the end of 2025, about 900 of them covered by collective bargaining agreements, and 52 percent of its 2025 net sales went to customers outside the United States. Facilities sit in the United States, the United Kingdom, Germany, Canada, Denmark, Finland, France, Switzerland, Argentina, Austria, Serbia and Mexico, some shared with EMG in China, Serbia and Mexico. No single customer is more than 2 percent of net sales, and approximately 4 percent of 2025 net sales went to the five largest.

What EIG makes

Process and analytical instrumentation is 70 percent of EIG's 2025 net sales. That covers process analysers, emission monitors and spectrometers, elemental and surface analysis instruments, level, pressure and temperature sensors and transmitters, radiation measurement devices, precision manufacturing systems, materials and force testing instruments, and contact and non-contact metrology, sold into power generation, pharmaceutical manufacturing, medical and healthcare, research, water and waste treatment, renewable energy, semiconductor manufacturing, emissions monitoring, and oil, gas and petrochemical refining. Three acquisitions widened the ultra-precision side of it: Virtek in October 2024, bringing laser-based projection and inspection systems; Kern in January 2025, high-precision machining and optical inspection; and FARO in July 2025, 3D measurement and imaging including portable measurement arms, laser scanners and trackers. The remaining 30 percent is aerospace and power instrumentation: power monitoring and metering, uninterruptible power supply systems, programmable power supplies, multifunction electric meters, communications equipment for smart grid, renewable energy and data centre applications, electromagnetic compatibility test equipment, sensors for electric vehicle testing and gas turbines, and dashboard instruments for heavy trucks. The aerospace line covers airborne data systems, turbine engine temperature measurement, vibration monitoring, cockpit instruments and displays, fuel and fluid measurement, embedded computing, and sensors and switches, sold across commercial aircraft, business jets, regional aircraft and helicopters and the military market. The filing points to a reputation as an established aerospace supplier of more than 70 years, long-standing relationships with aircraft, jet engine and original equipment manufacturers and system integrators, and a spare parts, repair and overhaul business for commercial aerospace.

Electromechanical

EMG designs and manufactures highly engineered medical components and devices, automation solutions, thermal management systems, specialty metals and electrical interconnects. It employed approximately 9,400 people at the end of 2025, about 2,300 of them covered by collective bargaining agreements, and 42 percent of its 2025 net sales went outside the United States. Facilities sit in the United States, the United Kingdom, China, Germany, France, Italy, Poland, Mexico, Serbia, Czechia, Malaysia and Taiwan. No single customer is more than 5 percent of net sales, and approximately 15 percent of 2025 net sales went to the five largest.

What EMG makes

Automation and engineered solutions is 70 percent of EMG's 2025 net sales: precision motion control, brushless motors, blowers and pumps, heat exchangers and other electromechanical systems, used in high-precision discrete automation including semiconductor, laboratory and medical equipment. Around that sit single-use and consumable surgical instruments, implantable components and drug delivery systems; electrical connectors and electronics packaging built for harsh environments; and specialised metal powder, strip, wire and bonded products used in medical, aerospace and defence, telecommunications, automotive and general industrial applications. EMG also supplies high-purity powdered metals, strip and foil, specialty clad metals and metal matrix composites, and its heat exchangers provide electronic cooling and environmental control for aerospace, defence and semiconductor customers. Its motors go into commercial appliances, food and beverage machines, hydraulic pumps and industrial blowers. The other 30 percent of EMG net sales is aerospace: motor-blower systems and heat exchangers for thermal management on military and commercial aircraft and military ground vehicles, plus third-party maintenance, repair and overhaul services delivered through a global network of facilities in the United States, Europe and Asia.

From AMETEK's annual report on Form 10-K for the year ended 31 December 2025. The filing

Compare with another name What $10,000 in AMETEK became

Latest results

Latest quarterQ3 FY2026ended 30 September 2026 · 10-Q filed 3 November 2026
Revenue
$2.2 billion
+17.3% on the year · +8.6% on the quarter
Q4 FY2024Q3 FY2026
Net income
$426 million
+14.8% on the year · +4.8% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$1.85
+15.6% on the year · +4.5% on the quarter
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Read the Q3 FY2026 results →the 10-Q on EDGAR ↗
Last full yearFY2025ended 31 December 2025 · 10-K filed 17 February 2026
Revenue
$7.4 billion
+6.6% on the year
FY2018FY2025
Net income
$1.5 billion
+7.6% on the year
FY2018FY2025
Diluted EPS
$6.40
+7.9% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in wordsAMETEK (AME) reported revenue of $7.4 billion for fiscal 2025, the year ended 31 December 2025, up 6.6% on the year before. Net income was $1.5 billion and diluted earnings per share $6.40. Revenue was $6.9 billion in fiscal 2024, $6.6 billion in fiscal 2023, $6.2 billion in fiscal 2022 and $5.5 billion in fiscal 2021. Net income in the same years was $1.4 billion, $1.3 billion, $1.2 billion and $990 million. Over the twelve months to 30 September 2026, AMETEK reported revenue of $8.2 billion and net income of $1.6 billion. Revenue grew 10.3% a year, compounded, over the five years to fiscal 2025. AMETEK declared $1.33 a share in dividends over the last four quarters and had 229 million shares outstanding at the latest filed count. At 30 September 2026 it carried $6.7 billion of debt and $666 million of cash. At the close of 6 November 2026 the market cap of AMETEK was $52.4 billion, 32.2 times its earnings over the last twelve months.
Read the FY2025 results →the 10-K on EDGAR ↗

Ratios

From the filings

ROE13.9%
ROCE11.6%
Operating margin26.0%
Net margin19.9%
FCF margin23.6%
Interest cover18.8x
Debt to equity0.57x
Cash conversion1.28x
Share count, last 12 months-0.4%
Sales CAGR, 3 years6.4%
Profit CAGR, 3 years8.5%
EPS, TTM$7.09

At the close of 6 November 2026

Price$228.64
Market cap$52.4 billion
Stock P/E32.2x
Price to book4.5x
EV / EBITDA22.8x
Dividend yield0.6%
Market cap / sales6.4x
52-week high$258.52
52-week low$189.90
Price, 1 year15.9%
Price CAGR, 3 years16.0%
Price CAGR, 5 years10.2%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the borrowing lines of AMETEK Inc.'s balance sheet, added together, finance leases inside them only where the company puts them there; operating leases are a separate line. Nothing here is a valuation or a view.
AMEgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue1,5041,4591,5151,5521,6261,5971,6461,6231,7311,7361,7351,7091,7621,7321,7781,8931,9981,9282,0442,220
Cost of revenue9829499881,0051,0641,0231,0531,0211,1161,1451,1101,0931,1171,1071,1421,2071,2781,2111,3091,410
Gross profit521510526547562575593602615591624616645625636686720718735810
Gross margin35%35%35%35%35%36%36%37%36%34%36%36%37%36%36%36%36%37%36%37%
SG&A160156162163164169174164170174177170176170174198215203207225
Operating income361353365385398406419438445417448446469455462488505515528585
Operating margin24%24%24%25%24%25%25%27%26%24%26%26%27%26%26%26%25%27%26%26%
Interest expense20.519.620.420.223.020.618.718.424.135.330.625.122.019.016.922.522.920.930.139.8
Pre-tax income339336346368379380396413417381417419444434442448474493492522
Tax rate17%19%18%19%19%19%18%18%18%18%19%19%13%19%19%17%16%19%17%18%
Net income282272282298307306324340343311338340387352358371399399407426
Net margin19%19%19%19%19%19%20%21%20%18%19%20%22%20%20%20%20%21%20%19%
Diluted EPS$1.21$1.17$1.22$1.29$1.33$1.32$1.40$1.47$1.48$1.34$1.45$1.47$1.67$1.52$1.55$1.60$1.73$1.74$1.77$1.85
Operating cash flow282201236327385387335473541410381487550418359441584452484561
Capital expenditure43.426.426.228.358.220.027.828.759.727.721.426.351.723.129.320.957.025.532.033.2
Free cash flow238175210299327367307444481383360461498394330420527426452527
Buybacks1.61571750.01.46.50.00.11.26.90.760.414418.00.114627027.90.20.1
Dividends paid46.250.850.450.450.557.557.657.657.664.764.764.764.771.571.571.471.077.877.977.9
Shares outstanding232m231m230m230m230m230m231m231m231m231m232m231m231m231m231m230m229m229m229m229m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTM
Revenue2,1372,5312,0982,4712,9903,3343,5944,0223,9743,8404,3004,8465,1594,5405,5476,1516,5976,9417,4018,192
Cost of revenuen/an/an/an/an/an/an/a2,6612,6182,5852,8613,1863,3712,9973,6344,0054,2124,4654,7345,208
Gross profitn/an/an/an/an/an/an/a1,3611,3561,2551,4391,6601,7881,5441,9132,1452,3842,4762,6672,983
Gross marginn/an/an/an/an/an/an/a33.8%34.1%32.7%33.5%34.2%34.7%34.0%34.5%34.9%36.1%35.7%36.0%36.4%
Research and developmentn/a57.550.556.878.084.993.9119116112130141162159194199221237236n/a
Selling, general and administrative263323254296349381398463449463535584610516604645677697757850
Operating income3874333664826367468158999087919041,0761,1771,0281,3091,5011,7071,7801,9102,134
Operating margin18.1%17.1%17.4%19.5%21.3%22.4%22.7%22.3%22.8%20.6%21.0%22.2%22.8%22.6%23.6%24.4%25.9%25.6%25.8%26.0%
Interest expense46.963.768.867.569.775.573.679.991.894.398.082.288.586.180.483.281.811381.3114
Pre-tax income3363662954065576627258058066937979881,0701,0821,2231,4291,6061,6621,7981,981
Income tax10811988.9122172203208220216181115210208210233269293285318350
Effective tax rate32.2%32.6%30.2%30.1%30.9%30.7%28.7%27.4%26.7%26.1%14.5%21.2%19.5%19.4%19.1%18.8%18.3%17.2%17.7%17.7%
Net income2282472062843844595175845915126817788618729901,1601,3131,3761,4801,631
Net margin10.7%9.8%9.8%11.5%12.9%13.8%14.4%14.5%14.9%13.3%15.8%16.1%16.7%19.2%17.9%18.9%19.9%19.8%20.0%19.9%
Diluted EPS$0.94$1.02$0.85$1.17$1.58$1.88$2.10$2.37$2.45$2.19$2.94$3.34$3.75$3.77$4.25$5.01$5.67$5.93$6.40$7.09
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Revenue by segment FY2009 to FY2025

FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
EIGn/an/an/a1,8732,0352,4222,4172,3602,6913,0293,3232,9903,7644,2294,6244,6604,91966.5%
EMGn/an/an/a1,4621,5601,6001,5571,4801,6101,8171,8361,5501,7831,9211,9732,2812,48233.5%
Electro-mechanical Group9521,1471,343n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
Electronic Instruments Group1,1471,3241,647n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
EIG FY2012 to FY2025EMG FY2012 to FY2025Electronic Instruments Group FY2009 to FY2011Electro-mechanical Group FY2009 to FY2011
2,471FY20103,594FY20133,840FY20165,159FY20196,151FY20227,401FY2025

$ million; hover a block for its figure and share; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Profit by segment FY2009 to FY2025

The operating profit each segment reports. Costs AMETEK does not charge to a segment are left out, so the segments can add up to more than the company's own operating profit.

FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Margin
FY2025
EIGn/an/an/a4975526136395716727828657719581,0901,3111,4281,44729.4%
EMGn/an/an/a29230933531827430736438832543750449745757923.3%
Electro-mechanical Group167210263n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
Electronic Instruments Group233316420n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
EIG FY2012 to FY2025Electronic Instruments Group FY2009 to FY2011EMG FY2012 to FY2025Electro-mechanical Group FY2009 to FY2011
527FY2010862FY2013845FY20161,253FY20191,593FY20222,026FY2025

$ million; the figure over a bar is all the segments together. Hover a block for its profit, sales and margin.

FY2025Share of salesShare of profit
EIG66%71%
EMG34%29%

Each column adds to 100%. A segment with a bigger share of the profit than of the sales makes more on each dollar it sells.

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where every segment with sales that year has an operating profit figure. A margin is a segment's operating profit over its own sales.

Revenue by product or service FY2018 to FY2025

FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
Process and analytical instrumentation2,1202,3942,1992,6273,0613,2683,2333,46446.8%
Aerospace and power1,3651,4201,2571,6431,7181,9452,0522,18729.6%
Automation and engineered solutions1,3601,3451,0841,2761,3711,3841,6571,75023.6%
Process and analytical instrumentationAerospace and powerAutomation and engineered solutions
4,846FY20185,159FY20194,540FY20205,547FY20216,151FY20226,597FY20236,941FY20247,401FY2025

$ million; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Revenue by region FY2009 to FY2025

FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
United States1,0671,2601,4891,6271,6101,8261,9201,8292,0862,3972,6842,3302,8013,1543,4693,6493,83151.8%
Asia3094055476206798077897868799859609601,1811,3171,3781,4321,48920.1%
European Union countries3393624565266276756166196927898266968869319459771,09014.7%
Other foreign countries2132693243714764944484174564784923834605385916497309.9%
United Kingdom1701751751902022212011891871971971722172102142342623.5%
United StatesAsiaEuropean Union countriesOther foreign countriesUnited Kingdom
2,471FY20103,594FY20133,840FY20165,159FY20196,151FY20227,401FY2025

$ million; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Cash flow

FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTM
Operating cash flow2792473654235096126617266737578339261,1141,2811,1601,1491,7351,8291,8022,080
Capital expenditure37.644.233.139.250.857.463.371.369.163.375.182.110274.2111139136127130148
Free cash flow2412033323844585555976556036947588431,0121,2071,0501,0101,5991,7021,6721,932
Free cash flow margin11.3%8.0%15.8%15.5%15.3%16.6%16.6%16.3%15.2%18.1%17.6%17.4%19.6%26.6%18.9%16.4%24.2%24.5%22.6%23.6%
Cash from investing-335-497-106-567-526-804-460n/an/a-452-626-1,210-1,15161.6-2,056-553-2,376-245-1,063-5,493
Cash from financing174173-10362.631.9175-70.3n/an/a57.1-32913.072.9-53939.3-576697-1,602-6863,648
Depreciation and amortisation52.763.365.572.986.5105119139149180183199234255292319338383423433
Share-based compensation15.520.213.516.622.119.421.619.923.822.025.127.340.441.646.147.446.247.947.850.2
Buybacks5.457.40.078.659.34.68.52454353366.936811.94.714.73337.8212434299
Dividends paid25.725.725.628.638.453.158.480.686.083.382.7129127165185202230259285305
Dividend per sharen/an/an/a$0.12$0.16$0.22$0.24$0.33$0.36$0.36$0.36$0.56$0.56n/an/an/an/an/an/an/a
Diluted shares, weighted242m242m243m241m243m244m246m247m242m234m232m233m229m231m233m232m232m232m231m230m
Shares outstanding at period endn/an/a364m241m241m243m245m241m236m229m231m227m229m230m232m230m231m231m229m229m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTM
Funded by
Shareholders' equity1,2411,2881,5671,7752,0532,5353,1363,2403,2553,2574,0284,2425,1155,9496,8727,4778,7309,65510,62911,696
Debtn/a1,0931,0421,1691,2641,4541,4151,7141,9382,3422,1742,6332,7692,4142,5442,3853,3132,0802,2836,669
Operating lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/an/a143128129129182190227224
Other liabilitiesn/a6756378751,0031,2011,3271,4671,4721,5031,5941,7881,8181,8662,3532,4402,7982,7062,9283,799
Total liabilities and equityn/a3,0563,2463,8194,3195,1905,8786,4216,6657,1017,7968,6629,84510,35711,89812,43115,02414,63116,06822,389
Owned
Fixed assetsn/a308310318325383403448485473493554549527617636891819855901
Goodwilln/a1,2401,2771,5741,8062,2082,4082,6142,7072,8193,1163,6124,0484,2255,2395,3736,4486,5567,17110,211
Intangible assetsn/a4425227629831,3101,4741,6261,6731,7342,0132,4042,7632,6243,3693,3424,1653,9154,1286,522
Investmentsn/a4.25.05.64.6n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
Securities held for sale or to maturityn/an/an/an/an/an/a8.29.28.57.38.17.7n/an/an/an/an/an/an/an/a
Cash and equivalents17087.02461631701582953783817176463543931,213347345410374458666
Receivablesn/a4063314004385085375856035926687337455978299191,0139491,1191,348
Inventoryn/a3503123353804294534965144925416256255597691,0441,1321,0221,1061,367
Other assetsn/a2192432622111943002652932653113737236137297729649971,2301,373
Total assetsn/a3,0563,2463,8194,3195,1905,8786,4216,6657,1017,7968,6629,84510,35711,89812,43115,02414,63116,06822,389
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded6.4%10.3%6.4%14.3%
Profit growth, compounded9.6%11.2%8.5%11.1%
Return on equity, average15.6%14.6%14.4%13.9%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was AMETEK's revenue in fiscal 2025?

AMETEK (AME) reported revenue of $7.4 billion for fiscal 2025, the year ended 31 December 2025, up 6.6% on the year before.

How much did AMETEK earn in fiscal 2025?

Net income was $1.5 billion for fiscal 2025, and diluted earnings per share $6.40.

What is AMETEK's P/E ratio?

At the close of 6 November 2026, AMETEK traded at 32.2 times its earnings over the twelve months to 30 September 2026.

What is AMETEK's market cap?

The market cap of AMETEK was $52.4 billion at the close of 6 November 2026.

Does AMETEK pay a dividend?

Yes. AMETEK declared $1.33 a share in dividends over the four quarters to 30 September 2026.

Peers: Measuring and Control Equipment

CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
Danaher Corp. DHR$162.0 billion37.698.1%20.4%5.5%0.490.6%
AMETEK Inc. AME$52.4 billion32.2513.9%26.0%14.3%0.570.6%
Roper Technologies Inc. ROP$47.2 billion18.8113.5%28.0%9.2%0.510.8%
Keysight Technologies, Inc. KEYS$46.3 billion37.3319.2%20.3%25.5%0.38n/a
Fortive Corp. FTV$19.5 billion31.1411.0%19.6%7.0%0.590.4%
MKS Inc. MKSI$13.0 billion22.8018.3%18.2%24.6%1.150.5%
Cognex Corp. CGNX$8.0 billion33.3714.1%25.0%15.8%0.000.7%
Ralliant Corp. RAL$7.5 billionn/a-73.4%-48.3%n/a0.710.3%
Sensata Technologies Holding plc ST$5.7 billion15.7212.0%15.1%4.1%0.781.2%
Mesa Laboratories Inc. MLAB$718 million152.762.5%9.0%3.0%0.760.5%
Senseonics Holdings, Inc. SENS$454 millionn/a-121.1%-223.2%90.6%0.62n/a
Hurco Companies Inc. HURC$132 millionn/a-3.4%-2.8%-1.9%n/an/a
All 49 in Measuring and Control Equipment
CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
Thermo Fisher Scientific Inc. TMO$257.5 billion36.6512.9%17.9%8.3%0.760.3%
KLA Corp. KLAC$180.5 billion34.6280.6%n/a15.8%0.880.6%
Danaher Corp. DHR$162.0 billion37.698.1%20.4%5.5%0.490.6%
Trane Technologies plc TT$88.0 billion28.3834.6%17.9%10.3%0.461.0%
AMETEK Inc. AME$52.4 billion32.2513.9%26.0%14.3%0.570.6%
Agilent Technologies, Inc. A$49.3 billion34.4019.6%22.2%8.6%0.540.6%
Roper Technologies Inc. ROP$47.2 billion18.8113.5%28.0%9.2%0.510.8%
Keysight Technologies, Inc. KEYS$46.3 billion37.3319.2%20.3%25.5%0.38n/a
Waters Corp. WAT$45.0 billion114.141.1%7.1%52.5%0.33n/a
Rockwell Automation, Inc. ROK$41.7 billion35.2134.4%22.7%11.3%0.931.5%
Coherent Corp. COHR$38.0 billion40.018.5%12.5%30.8%0.35n/a
Mettler Toledo International Inc. MTD$37.3 billion37.301,202.8%n/a6.5%26.06n/a
Teradyne, Inc. TER$34.1 billion25.0537.2%32.1%74.9%0.000.2%
Illumina, Inc. ILMN$32.2 billion36.6728.5%21.2%5.8%0.57n/a
Veralto Corp. VLTO$28.5 billion28.9831.0%21.8%6.4%0.900.4%
Fortive Corp. FTV$19.5 billion31.1411.0%19.6%7.0%0.590.4%
Revvity, Inc. RVTY$17.3 billion73.893.3%12.3%4.1%0.450.2%
MKS Inc. MKSI$13.0 billion22.8018.3%18.2%24.6%1.150.5%
Trimble Inc. TRMB$12.4 billionn/a-3.2%16.5%6.9%0.31n/a
Avantor, Inc. AVTR$10.5 billion30.935.8%7.3%0.9%0.63n/a
Bio-Rad Laboratories, Inc. BIO$10.3 billion10.0613.5%-2.4%1.4%0.16n/a
Bruker Corp. BRKR$9.4 billionn/a-5.4%-2.0%2.2%0.74n/a
Onto Innovation Inc. ONTO$8.5 billion65.106.9%12.0%8.1%0.00n/a
Cognex Corp. CGNX$8.0 billion33.3714.1%25.0%15.8%0.000.7%
10x Genomics, Inc. TXG$7.8 billionn/a-8.0%-11.7%-3.6%0.00n/a
Ralliant Corp. RAL$7.5 billionn/a-73.4%-48.3%n/a0.710.3%
Sensata Technologies Holding plc ST$5.7 billion15.7212.0%15.1%4.1%0.781.2%
Vontier Corp. VNT$5.7 billion17.3028.4%19.4%0.3%1.570.2%
Badger Meter Inc. BMI$4.5 billion36.4719.4%18.8%-2.2%0.001.0%
Mirion Technologies, Inc. MIR$4.4 billion149.581.6%6.0%19.6%0.67n/a
Itron, Inc. ITRI$4.3 billion15.9016.5%13.7%-3.6%0.95n/a
Alamar Biosciences, Inc. ALMR$1.9 billionn/a-18.1%-42.1%n/a0.00n/a
Cohu Inc. COHU$1.9 billionn/a-2.9%-2.4%34.0%0.38n/a
Aehr Test Systems AEHR$1.7 billion1,338.881.0%-5.6%26.8%0.00n/a
Allient Inc. ALNT$1.4 billion36.6811.4%9.8%12.6%0.530.2%
Transcat Inc. TRNS$953 millionn/an/an/an/a0.38n/a
Cytek Biosciences, Inc. CTKB$765 millionn/a-25.3%-21.1%5.5%0.00n/a
Mesa Laboratories Inc. MLAB$718 million152.762.5%9.0%3.0%0.760.5%
Pacific Biosciences of California, Inc. PACB$703 millionn/an/a-81.3%4.4%n/a0.0%
Frequency Electronics Inc. FEIM$661 million241.042.2%2.5%6.3%0.00n/a
Senseonics Holdings, Inc. SENS$454 millionn/a-121.1%-223.2%90.6%0.62n/a
908 Devices Inc. MASS$402 millionn/an/an/an/a0.00n/a
Quantum-Si Inc. QSI$291 millionn/a-53.1%-7,474.5%-60.2%0.00n/a
Nautilus Biotechnology, Inc. NAUT$284 millionn/an/an/an/a0.00n/a
Intest Corp. INTT$173 million38.593.4%3.3%16.6%0.05n/a
Hurco Companies Inc. HURC$132 millionn/a-3.4%-2.8%-1.9%n/an/a
Kewaunee Scientific Corp. KEQU$97 million12.1411.0%5.4%5.3%0.25n/a
Seer, Inc. SEER$90 millionn/a-30.1%-498.2%-12.7%0.000.0%
Rapid Micro Biosystems, Inc. RPID$32 millionn/a-288.5%-141.5%16.1%1.08n/a
11 companies share its SEC industry code (Industrial Instruments For Measurement, Display, And Control); the rest are the names nearest in size in its wider industry, Measuring and Control Equipment, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on AME

Dividends$1.33 a share over the four quarters to 30 September 2026, a 0.58% yield
Filings23 in twelve months: 14 current reports (8-K), about 7 other events; 4 results of operations; 3 officer or director change; 1 material agreement; 1 new financial obligation
Planned insider sales7 Form 144 notices in twelve months, $29.5 million; latest 7 August 2026
Options tapeput/call 0.27 by open interest at the 6 November 2026 close; the straddle prices a 5.0% move to 20 November 2026
13F holders1,205 funds reported a position for the quarter to 30 June 2026; largest BlackRock, Inc.
Insider trading9 sales and 1 purchase on Form 4 in twelve months
Congress0 House trades disclosed in six months
Short interest3.7 million shares short, 2.95 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 3 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q30 September 20263 November 2026EDGAR
10-Q30 June 20264 August 2026EDGAR
10-Q31 March 202630 April 2026EDGAR
10-K31 December 202517 February 2026EDGAR
10-Q30 September 202530 October 2025EDGAR
10-Q30 June 202531 July 2025EDGAR
10-Q31 March 20251 May 2025EDGAR
10-K31 December 202420 February 2025EDGAR
10-Q30 September 202431 October 2024EDGAR
10-Q30 June 20241 August 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.